These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6705267)

  • 1. Antibodies directed against human liver specific membrane lipoprotein (LSP) in marmosets experimentally infected with the hepatitis A virus.
    Jensen DM; Peterson DA; Wolfe LG; Hurley T; Payne JA; Ogden J
    Clin Exp Immunol; 1984 Mar; 55(3):535-40. PubMed ID: 6705267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver autoreactivity in acute virus A, B and non-A, non-B hepatitis.
    Vento S; McFarlane BM; McSorley CG; Ranieri S; Giuliani-Piccari G; Dal Monte PR; Verucchi G; Williams R; Chiodo F; McFarlane IG
    J Clin Lab Immunol; 1988 Jan; 25(1):1-7. PubMed ID: 3133482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species cross-reactivity of anti-LSP antibodies in acute viral hepatitis.
    Perperas A; McFarlane BM; McSorley CG; McFarlane IG; Williams R
    J Clin Lab Immunol; 1986 Jan; 19(1):25-30. PubMed ID: 2422379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
    Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
    Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
    Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to liver-specific lipoprotein following hepatitis induced by mouse cytomegalovirus.
    Bartholomaeus WN; Shellam GR; Allan JE; Reed WD; Joske RA
    Clin Exp Immunol; 1983 Apr; 52(1):89-97. PubMed ID: 6305543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver membrane autoantibodies: methods for their detection and clinical significance.
    Nagai S; Manns M; Meyer zum Büschenfelde KH
    Tokai J Exp Clin Med; 1982 Mar; 7(2):145-58. PubMed ID: 7048633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
    Ortona L; Laghi V; Tamburrini E; Troncone L; Bonifazi N; Nervo P; Cauda R
    Clin Exp Immunol; 1983 May; 52(2):437-40. PubMed ID: 6861379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymus-dependence of autoantibody responses to liver specific lipoprotein in the mouse.
    Bartholomaeus WN; O'Donoghue H; Reed WD
    Clin Exp Immunol; 1984 Mar; 55(3):541-5. PubMed ID: 6323073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody responses to liver-specific lipoprotein in mice.
    Bartholomaeus WN; Reed WD; Joske RA; Shilkin KB
    Immunology; 1981 Jun; 43(2):219-26. PubMed ID: 7019049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP).
    McFarlane IG; McFarlane BM; Major GN; Tolley P; Williams R
    Clin Exp Immunol; 1984 Feb; 55(2):347-54. PubMed ID: 6199139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits.
    Uibo RM; Helin HJ; Krohn KJ
    Clin Exp Immunol; 1982 May; 48(2):505-12. PubMed ID: 7105494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to liver-specific lipoprotein in acute and chronic liver diseases. Its quantitative assay with monoclonal antibody, but without the use of liver-specific lipoprotein.
    Kakumu S; Yoshioka K; Tsubouchi A
    Gastroenterol Jpn; 1985 Jun; 20(3):216-21. PubMed ID: 3930337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental infection of marmosets with hepatitis A virus.
    Ebert JW; Maynard JE; Bradley DW; Lorenz D; Krushak DH
    Primates Med; 1978; 10():295-9. PubMed ID: 205859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental models of hepatitis A in macaques using viral strains isolated from man and monkeys].
    Korzaia LI; Esvandzhiia NCh; Lomovskaia IB; Krylova RI; Shevtsova ZV
    Mikrobiol Z; 1994; 56(1):22-9. PubMed ID: 8087252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
    Anand AC; Nagpal AK; Seth AK; Dhot PS
    J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of cellular immunity in experimental autoimmune hepatitis in mice.
    Mori Y; Mori T; Yoshida H; Ueda S; Iesato K; Wakashin Y; Wakashin M; Okuda K
    Clin Exp Immunol; 1984 Jul; 57(1):85-92. PubMed ID: 6430615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
    Cao J; Meng S; Li C; Ji Y; Meng Q; Zhang Q; Liu F; Li J; Bi S; Li D; Liang M
    J Med Virol; 2008 Jul; 80(7):1171-80. PubMed ID: 18461629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice.
    Watanabe Y; Kawakami H; Kawamoto H; Ikemoto Y; Masuda K; Takezaki E; Nakanishi T; Kajiyama G; Takeno H
    Clin Exp Immunol; 1987 Jan; 67(1):105-13. PubMed ID: 3621670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between liver-specific lipoprotein and the hepatocyte plasma membrane.
    Bartholomaeus WN; Swanson NR; Reed WD; O'Donoghue HL; Foti D; Papadimitriou JM
    Immunology; 1987 Mar; 60(3):321-9. PubMed ID: 3032778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.